MedPageToday
MedPage Today) — SAN FRANCISCO — Circulating tumor DNA (ctDNA) measurements showed promise for identifying patients with early colorectal cancer (CRC) most likely to benefit from adjuvant therapy, analyses of two large clinical trials suggested…
Read More
ctDNA Testing Shows Promise for Influencing Colorectal Cancer Treatment
MedPage Today) — SAN FRANCISCO — Circulating tumor DNA (ctDNA) measurements showed promise for identifying patients with early colorectal cancer (CRC) most likely to benefit from adjuvant therapy, analyses of two large clinical trials suggested…